{
    "2020-02-13": [
        [
            {
                "time": "2023-10-10",
                "original_text": "FORM 8.3 - ABBVIE INC AbbVie's SKYRIZIâ„¢ Now Listed on the Nova Scotia Formulary for the Treatment of Moderate to Severe Plaque Psoriasis",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "SKYRIZI",
                        "Nova Scotia Formulary",
                        "Moderate to Severe Plaque Psoriasis"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}